Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

A blood test can determine whether memory loss is caused by Alzheimer’s disease with more than 90 percent accuracy, according to a new study published Sunday. A group of researchers at Lund University ...

When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid plaques that are a hallmark of the disease. But the results of that test ...

More than 7 million Americans aged 65 and older have Alzheimer's disease, the most common form of dementia. Yet average wait times for a dementia diagnosis range from 12 months to nearly four years.

In fact, there is another common cognitive disorder with very similar symptoms, called limbic-predominant age-related TDP-43 encephalopathy — or LATE for short — that is often misdiagnosed as ...

Scientists at Mayo Clinic in Minnesota say they have identified a new type of memory loss. Limbic-predominant amnestic neurodegenerative syndrome, or LANS, affects the brain's limbic system, which ...

Residents over the age of 60 in seven central New York communities: Cayuga, Herkimer, Lewis, Madison, Oneida, Oswego and Tompkins, will be able to receive free memory screenings from their local ...

Findings seen in pilot study of older adults with mild cognitive impairment, but other coprimary outcomes did not meet significance thresholds.

Stress is the brain’s natural response to fear, but it often disrupts memory in the process, potentially impacting the possibility of memory loss. When preparing for a big presentation or taking a ...

A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.